BEYOND MEDICAL TECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 USD | -.--% |
|
-.--% | -.--% |
| 04-30 | Beyond Medical Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-24 | Beyond Medical Technologies Inc. Announces Chief Financial Officer Changes | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 21.33 | 3.665 | 5.452 | 2.69 | 0.0644 | 0.2088 |
| Enterprise Value (EV) 1 | 15.15 | 0.6488 | 4.993 | 1.344 | -0.4724 | 0.1747 |
| P/E ratio | -6.46 x | -0.68 x | -0.71 x | -0.88 x | -0.05 x | -0.35 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 26,128,627 x | 2,850,890 x | - | - |
| EV / Revenue | - | - | 23,927,921 x | 1,424,518 x | - | - |
| EV / EBITDA | -5.46 x | -0.2 x | -2.55 x | -0.68 x | 0.61 x | - |
| EV / FCF | -7.91 x | -0.26 x | -3.08 x | -2.04 x | 19.9 x | -0.68 x |
| FCF Yield | -12.6% | -380% | -32.5% | -49.1% | 5.02% | -147% |
| Price to Book | 2.67 x | 1.04 x | 3.68 x | 1.75 x | 0.25 x | -0.62 x |
| Nbr of stocks (in thousands) | 3,762 | 3,951 | 5,601 | 7,914 | 7,914 | 7,914 |
| Reference price 2 | 5.671 | 0.9275 | 0.9734 | 0.3399 | 0.008132 | 0.0264 |
| Announcement Date | 19-04-29 | 20-04-28 | 21-04-30 | 22-05-02 | 23-05-01 | 24-04-30 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 0.2087 | 0.9434 | - | - |
| EBITDA 1 | -2.774 | -3.167 | -1.959 | -1.975 | -0.7732 | - |
| EBIT 1 | -2.799 | -3.216 | -2.029 | -2.077 | -0.7993 | -0.514 |
| Operating Margin | - | - | -972.42% | -220.1% | - | - |
| Earnings before Tax (EBT) 1 | -3.208 | -5.366 | -6.521 | -2.913 | -0.8351 | -0.552 |
| Net income 1 | -3.208 | -5.366 | -6.521 | -2.913 | -1.401 | -0.596 |
| Net margin | - | - | -3,125.16% | -308.74% | - | - |
| EPS 2 | -0.8778 | -1.362 | -1.374 | -0.3864 | -0.1770 | -0.0753 |
| Free Cash Flow 1 | -1.914 | -2.469 | -1.622 | -0.6602 | -0.0237 | -0.2568 |
| FCF margin | - | - | -777.4% | -69.98% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 19-04-29 | 20-04-28 | 21-04-30 | 22-05-02 | 23-05-01 | 24-04-30 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 6.19 | 3.02 | 0.46 | 1.35 | 0.54 | 0.03 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.91 | -2.47 | -1.62 | -0.66 | -0.02 | -0.26 |
| ROE (net income / shareholders' equity) | -46.2% | -91.3% | -260% | -193% | -92.7% | 1,503% |
| ROA (Net income/ Total Assets) | -24.5% | -32.6% | -44.6% | -68.4% | -39% | -91.3% |
| Assets 1 | 13.1 | 16.48 | 14.62 | 4.261 | 3.591 | 0.6528 |
| Book Value Per Share 2 | 2.120 | 0.9000 | 0.2600 | 0.1900 | 0.0300 | -0.0400 |
| Cash Flow per Share 2 | 0.8000 | 0.7000 | 0.1100 | 0.1800 | 0.0700 | 0.0100 |
| Capex 1 | 1.59 | 1.18 | 0.23 | 0.07 | - | - |
| Capex / Sales | - | - | 112.2% | 7.21% | - | - |
| Announcement Date | 19-04-29 | 20-04-28 | 21-04-30 | 22-05-02 | 23-05-01 | 24-04-30 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 158K | |
| -10.23% | 3.38B | |
| +11.71% | 1.73B | |
| +7.93% | 1.16B | |
| +13.26% | 1.06B | |
| -0.59% | 614M | |
| -8.42% | 608M | |
| +14.04% | 588M | |
| -14.10% | 548M | |
| -18.13% | 534M |
- Stock Market
- Equities
- DOCKF Stock
- Financials Beyond Medical Technologies Inc.
